The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Recruiting

Phase 2

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Sponsor:

Weill Medical College of Cornell University

Code:

NCT00281502

Conditions

Hepatic Encephalopathy

Hepatitis C

Liver Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Rifaximin (drug)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2010-11-05.